铁死亡在急性肾损伤中的分子机制及治疗靶点研究进展

Research progress on the molecular mechanism and therapeutic targets of ferroptosis in acute kidney injury

  • 摘要: 急性肾损伤(AKI)是临床最常见、最严重的肾病综合征之一,也是器官移植术后最常见的严重并发症之一,其发生率和病死率都很高。铁是生物体内必需的微量元素,铁死亡是由铁介导的脂质过氧化积累诱发的一种程序性细胞死亡形式,其发生过程与铁代谢、脂代谢、氨基酸代谢和多种信号通路密切相关。最新研究表明,铁死亡在AKI发生发展中起着关键作用,并为AKI的治疗提供了靶点。本文总结了铁死亡的调控机制及其在AKI中的作用,同时也总结了通过抑制铁死亡在预防和治疗AKI中发挥重要作用的化合物,为未来AKI的治疗和研究提供了新思路。

     

    Abstract: Acute kidney injury (AKI) is one of the most common and severe nephropathy syndromes in clinical practice and also one of the most common serious complications after organ transplantation, with high incidence and fatality. Iron is an essential trace element in the body. Ferroptosis is a form of programmed cell death induced by the accumulation of iron-mediated lipid peroxidation, and its occurrence is closely related to iron metabolism, lipid metabolism, amino acid metabolism and multiple signaling pathways. Recent studies have shown that ferroptosis plays a key role in the occurrence and development of AKI and provides therapeutic targets for AKI. This article summarizes the regulatory mechanism of ferroptosis and its role in AKI, as well as the compounds that play an important role in the prevention and treatment of AKI by inhibiting ferroptosis, providing new ideas for the future treatment and research of AKI.

     

/

返回文章
返回